MetLife Investment Management’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96.4K | Buy |
+39,014
| New | +$96.4K | ﹤0.01% | 2560 |
|
|
2025
Q1 | – | Sell |
-25,031
| Closed | -$73.1K | – | 2818 |
|
|
2024
Q4 | $73.1K | Sell |
25,031
-9,097
| -27% | -$26.6K | ﹤0.01% | 2702 |
|
|
2024
Q3 | $132K | Hold |
34,128
| – | – | ﹤0.01% | 2508 |
|
|
2024
Q2 | $175K | Buy |
34,128
+12,866
| +61% | +$66.1K | ﹤0.01% | 2332 |
|
|
2024
Q1 | $149K | Hold |
21,262
| – | – | ﹤0.01% | 2350 |
|
|
2023
Q4 | $188K | Hold |
21,262
| – | – | ﹤0.01% | 2273 |
|
|
2023
Q3 | $203K | Hold |
21,262
| – | – | ﹤0.01% | 2199 |
|
|
2023
Q2 | $311K | Buy |
21,262
+15,171
| +249% | +$222K | ﹤0.01% | 1992 |
|
|
2023
Q1 | $74.9K | Hold |
6,091
| – | – | ﹤0.01% | 2656 |
|
|
2022
Q4 | $113K | Buy |
+6,091
| New | +$113K | ﹤0.01% | 2543 |
|